相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness
David M. Morens et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection
Keer Sun et al.
NATURE MEDICINE (2008)
Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004
Fangjun Zhou et al.
PEDIATRICS (2008)
Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults
Jennifer C. Nelson et al.
VACCINE (2008)
Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic
M. Ruby Siddiqui et al.
EMERGING INFECTIOUS DISEASES (2008)
Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects
Adam Lloyd et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2008)
Deaths from bacterial pneumonia during 1918-19 influenza pandemic
John F. Brundage et al.
EMERGING INFECTIOUS DISEASES (2008)
Enhanced decision support for policy makers using a web interface to health-economic models - Illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands
G. A. A. Hubben et al.
VACCINE (2007)
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
Carlos G. Grijalva et al.
LANCET (2007)
The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: An international model
Samuel Aballea et al.
VALUE IN HEALTH (2007)
Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis
Christopher J. L. Murray et al.
LANCET (2006)
Health benefits, risks, and cost-effectiveness of influenza vaccination of children
Lisa A. Prosser et al.
EMERGING INFECTIOUS DISEASES (2006)
National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States
Carlos G. Grijalva et al.
PEDIATRICS (2006)
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia - Updated analysis using World Health Organization standardized interpretation of chest radiographs
John Hansen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program
Torbjorn Wisloff et al.
VACCINE (2006)
Insights into the interaction between influenza virus and pneumococcus
Jonathan A. McCullers
CLINICAL MICROBIOLOGY REVIEWS (2006)
Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores
Janel Hanmer et al.
MEDICAL DECISION MAKING (2006)
Cost-effectiveness of pneurnococcal conjugate vaccine - Evidence from the first 5 years of use in the United States incorporating herd effects
G. Thomas Ray et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness
JF Brundage
LANCET INFECTIOUS DISEASES (2006)
Occurrence of invasive pneumococcal disease and number of excess cases due to influenza
Katarzyna Grabowska et al.
BMC INFECTIOUS DISEASES (2006)
Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States
CW Shepard et al.
PEDIATRICS (2005)
Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir
BL Nordstrom et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
A role for Streptococcus pneumoniae in virus-associated pneumonia
SA Madhi et al.
NATURE MEDICINE (2004)
Respiratory viruses predisposing to bacterial infections: role of neuraminidase
VT Peltola et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales
A Melegaro et al.
VACCINE (2004)
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection
KP Klugman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine
EDG McIntosh et al.
VACCINE (2003)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
SB Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis - A head-to-head comparison
R Oostenbrink et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2002)
Lethal Synergism between influenza virus and Streptococcus pneumoniae:: Characterization of a mouse model and the role of platelet-activating factor receptor
JA McCullers et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Updating the accounts: global mortality of the 1918-1920 Spanish influenza pandemic
NPAS Johnson et al.
BULLETIN OF THE HISTORY OF MEDICINE (2002)
Complications of meningococcal disease in college students
LJ Erickson et al.
CLINICAL INFECTIOUS DISEASES (2001)
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998 -: Opportunities for prevention in the conjugate vaccine era
KA Robinson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza
KL Nichol
ARCHIVES OF INTERNAL MEDICINE (2001)
Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children
TA Lieu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
S Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
分享论文
